Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Open in Screener

TEM

Tempus AI Inc

Nov 04 • 12:35PM ET

87.82

-0.89 -1.00 %

Healthcare • Health Information Services • USA • NASD

Peers: ILMN EXAS GH TXG CRSP PACB NTLA EDIT CDNA TWST

| Held by: ARKK VTI VB ARKG VBK VXF BAI IBB IWP JTEK

Index	-	P/E	-	EPS (ttm)	-1.18	Insider Own	44.60%	Shs Outstand	168.58M	Perf Week	1.42%
Market Cap	15.26B	Forward P/E	-	EPS next Y	-0.21	Insider Trans	-2.74%	Shs Float	96.58M	Perf Month	-5.65%
Enterprise Value	15.82B	PEG	-	EPS next Q	-0.17	Inst Own	43.38%	Short Float	22.91%	Perf Quarter	58.15%
Income	-199.73M	P/S	16.03	EPS this Y	57.14%	Inst Trans	7.01%	Short Ratio	2.40	Perf Half Y	68.27%
Sales	951.98M	P/B	49.26	EPS next Y	68.27%	ROA	-16.04%	Short Interest	22.13M	Perf YTD	160.14%
Book/sh	1.78	P/C	52.37	EPS next 5Y	-	ROE	-97.95%	52W High	104.32 -15.81%	Perf Year	96.82%
Cash/sh	1.68	P/FCF	-	EPS past 3/5Y	-37.97% -32.48%	ROIC	-17.32%	52W Low	31.36 180.05%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	39.06% 38.58%	Gross Margin	59.21%	Volatility	5.22% 6.37%	Perf 5Y	-
Dividend TTM	-	EV/Sales	16.62	EPS Y/Y TTM	76.46%	Oper. Margin	-23.80%	ATR (14)	5.47	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.43	Sales Y/Y TTM	59.84%	Profit Margin	-20.98%	RSI (14)	49.50	Recom	2.06
Dividend Gr. 3/5Y	- -	Current Ratio	1.54	EPS Q/Q	93.25%	SMA20	-3.32%	Beta	4.91	Target Price	85.77
Payout	-	Debt/Eq	2.76	Sales Q/Q	89.57%	SMA50	2.22%	Rel Volume	0.94	Prev Close	88.71
Employees	2400	LT Debt/Eq	2.73	Earnings	Nov 04 AMC	SMA200	33.55%	Avg Volume	9.21M	Price	87.82
IPO	Jun 14, 2024	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.31% 5.67%	Trades		Volume	4,331,214	Change	-1.00%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Downgrade	TD Cowen	Buy → Hold	$88
Oct-20-25	Initiated	Canaccord Genuity	Buy	$110
Sep-02-25	Initiated	H.C. Wainwright	Buy	$90
Apr-21-25	Initiated	BTIG Research	Buy	$60
Feb-25-25	Downgrade	JP Morgan	Overweight → Neutral	$50 → $55
Feb-12-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-05-25	Resumed	TD Cowen	Buy	$58 → $74
Dec-13-24	Initiated	Wolfe Research	Outperform	$60
Dec-09-24	Initiated	Guggenheim	Buy	$74
Nov-11-24	Downgrade	Stifel	Buy → Hold	$45 → $65
Oct-02-24	Downgrade	BofA Securities	Buy → Neutral	$45 → $60
Aug-12-24	Initiated	Piper Sandler	Neutral	$40
Jul-09-24	Initiated	William Blair	Outperform
Jul-09-24	Initiated	TD Cowen	Buy	$50
Jul-09-24	Initiated	Stifel	Buy	$45
Jul-09-24	Initiated	Needham	Buy	$47
Jul-09-24	Initiated	Morgan Stanley	Overweight	$44
Jul-09-24	Initiated	Loop Capital	Buy	$48
Jul-09-24	Initiated	Longbow	Buy	$48
Jul-09-24	Initiated	JP Morgan	Overweight	$42

Show Previous Ratings

Today 06:01AM	Sex Dolls, Boycotts, Protests: Furor in France as Shein Opens Paris Store (The Wall Street Journal)
Nov-03-25 04:36PM	Sex Dolls, Boycotts, Protests: Furor in France as Shein Opens Paris Store (The Wall Street Journal)
07:19AM	Tempus AI Inc (TEM) Q3 2025 Earnings Report Preview: What To Expect (GuruFocus.com)
Oct-31-25 10:46AM	This AI Health Stock is Up Over 150% This Yearand Its Not Slowing Down (24/7 Wall St.)
Oct-30-25 07:45AM	Omnicell (OMCL) Q3 Earnings and Revenues Surpass Estimates (Zacks)
08:57AM	Loading…
Oct-29-25 08:57AM	TEM vs. EXAS: Which Genomics Player Offers Greater Upside? (Zacks)
Oct-28-25 08:30AM	Tempus to Participate in the Stifel 2025 Healthcare Conference (Business Wire) -5.45%
05:53AM	Tempus AI (TEM) Stock Gets a $110 Price Target on Rising AI Adoption in Medicine (Insider Monkey)
Oct-27-25 09:20AM	Tempus AI Enhances AI-Driven Diagnostics With Multiple FDA Approvals (Zacks)
Oct-21-25 09:47AM	Tempus AI valuation catches up with its growth, says TD Cowen downgrading stock (Investing.com)
09:32AM	Goldman downgraded, Coinbase initiated: Wall Street's top analyst calls (The Fly)
08:30AM	Tempus to Report Third Quarter 2025 Financial Results on November 4 (Business Wire)
Oct-20-25 06:36PM	Why Tempus AI Stock Raced More Than 5% Higher Today (Motley Fool) +5.32%
04:56PM	These Stocks Moved the Most Today: Apple, Amazon, TSMC, Cleveland-Cliffs, Super Micro, Cooper Cos., Tesla, Netflix, and More (Barrons.com)
09:34AM	Apple upgraded, Rivian downgraded: Wall Street's top analyst calls (The Fly)
09:03AM	Loading…
09:03AM	Tempus AI Stock Before Q3 Earnings Release: To Buy or Not to Buy? (Zacks)
09:00AM	Ambry Genetics Announces 10-Year Study in Genetics in Medicine Highlighting the Impact of Proactive Exome Reanalysis for Healthcare Equity (Business Wire)
Oct-17-25 09:45AM	Tempus AI Fuels Growth Through Strategic Biotech Collaborations (Zacks)
Oct-16-25 12:36PM	Hims & Hers Elevates Technology-Driven Healthcare Accessibility (Zacks)
08:30AM	Tempus Announces Collaboration with Whitehawk Therapeutics to Advance Biomarker-Driven Oncology Research (Business Wire)
Oct-15-25 01:49PM	Tempus AI Hits $100-Are Shares Due for a Pullback? (MarketBeat)
08:30AM	Tempus Announces Six Abstracts Accepted for Presentation at the European Society for Medical Oncology Congress 2025 (Business Wire)
Oct-14-25 03:00PM	NVDA & PLTR Driving AI in Health: Top Health IT Stocks for Q3 Earnings (Zacks)
Oct-10-25 08:44AM	TEM Expands Partnership With Northwestern Medicine Amid AI Boom (Zacks)
Oct-09-25 10:54AM	Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell? (Zacks)
08:30AM	Tempus Selected by ARPA-H to Provide CRO and Testing Services for the ADAPT Program, Advancing Precision Cancer Therapy (Business Wire)
Oct-08-25 05:48PM	These 5 Beaten-Down Tech Stocks Could Catch Fire Next (MarketBeat) +11.01%
11:22AM	Tempus AI, Inc. (TEM): A Bull Case Theory (Insider Monkey)
10:58AM	Breakthrough Discoveries Unlock $643B Cancer Treatment Market By 2034 (PR Newswire)
Oct-05-25 02:42AM	Tempus AI, Inc. (TEM) Secures FDA Clearance for xR IVD Device to Enhance Drug Discovery (Insider Monkey)
05:30AM	Loading…
Oct-03-25 05:30AM	Why Tempus AI Stock Was Motoring Higher This Week (Motley Fool)
Oct-01-25 12:24PM	Ambry Genetics Announces Improved EHR-Integrated Breast Cancer Risk Assessment Solution with Upgraded Tyrer-Cuzick Scoring Approach Incorporating Breast Density (Business Wire) +9.02%
Sep-27-25 11:13AM	3 Healthcare Stocks Using AI to Drive Growth (MarketBeat)
08:45AM	What Are 2 Great Tech Stocks to Buy Right Now? (Motley Fool)
Sep-26-25 09:21AM	TEM vs. ILMN: Which Precision Oncology Stock Is Worth Buying Now? (Zacks)
Sep-25-25 06:53PM	Why Tempus AI Stock Is Plunging This Week (Motley Fool)
Sep-23-25 08:32AM	Tempus AI Enhances Cancer Research Tools With FDA-Cleared xR IVD (Zacks)
Sep-22-25 04:07PM	IBD 50's Tempus AI Pulls Back From Record High After Another FDA Clearance (Investor's Business Daily)
12:45PM	Hims & Hers Expands Care Ecosystem via Global and Digital Innovation (Zacks)
10:04AM	IBD 50's Tempus AI Hits Record High On Yet Another FDA Clearance (Investor's Business Daily)
09:00AM	3 Big Short Interest Names with Bullish Setups (MarketBeat)
08:30AM	Tempus Receives U.S. FDA 510(k) Clearance for Tempus xR IVD, its RNA NGS In Vitro Diagnostic Device (Business Wire)
Sep-21-25 09:30AM	Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook (Insider Monkey)
Sep-18-25 08:45AM	Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises (PR Newswire)
Sep-16-25 08:20AM	TEM Strengthens Radiology Portfolio With Pixel's FDA Clearance (Zacks)
Sep-15-25 08:00AM	Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease (PR Newswire)
Sep-12-25 09:42AM	Tempus AI (TEM) Touches 7-Month High on Pixel FDA Approval (Insider Monkey)
08:43AM	Tempus (TEM) Stock Jumps 13.6%: Will It Continue to Soar? (Zacks)
Sep-11-25 06:26PM	Why Tempus AI Stock Soared Nearly 14% Higher Today (Motley Fool) +13.59%
05:01PM	Northwestern Medicine Integrates Tempus AI's "David" Clinical Assistant into EHR Platform (Insider Monkey)
01:58PM	Tempus AI Gains FDA Clearance For Updated Pixel To Boost Accuracy And Efficiency In Cardiac Imaging (Benzinga)
11:11AM	Tempus AI Surges, Flirting With A Profit-Taking Zone, On A Fresh FDA Move (Investor's Business Daily)
08:35AM	TEM Gains Validation for PurIST Amid Evolving Cancer Care Landscape (Zacks)
08:30AM	Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device (Business Wire)
Sep-09-25 08:44AM	TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell? (Zacks)
08:30AM	Tempus Announces New Study in JCO Precision Oncology Validating PurIST Algorithm for Enhanced Therapy Selection in Pancreatic Cancer (Business Wire)
Sep-04-25 12:30PM	What's Fueling Tempus AI's Q2 Net Loss Improvement Momentum? (Zacks)
08:30AM	Northwestern Medicine Becomes First Health System to Integrate Tempus' Generative AI Co-Pilot, David, Into Its EHR Platform (Business Wire)
Sep-03-25 04:01PM	Tempus to Participate in Morgan Stanleys 23rd Annual Global Healthcare Conference (Business Wire)
Sep-02-25 10:40AM	3 Heavily Shorted Stocks That Could Prove the Bears Wrong (MarketBeat)
09:45AM	Elf Beauty downgraded, Zscaler upgraded: Wall Street's top analyst calls (The Fly)
Aug-29-25 11:42PM	Tempus AI, Inc. (TEM) Expands into Digital Pathology with Paige Acquisition (Insider Monkey)
04:36PM	Tempus AI Stock Required A Tempered Position (Investor's Business Daily)
Aug-27-25 10:44AM	Hims & Hers Scales Growth Through Subscriptions and Care Expansion (Zacks)
Aug-26-25 08:42AM	Tempus' Key Acquisitions Strengthen Its AI Healthcare Leadership (Zacks)
06:00AM	Tempus inks $81M Paige buyout to support AI model development (MedTech Dive)
Aug-25-25 03:00PM	Tempus AI or Butterfly: Which AI Health Tech Stock is a Buy Now? (Zacks) -5.74%
10:30AM	BC-Most Active Stocks (Associated Press Finance)
09:12AM	Zacks Market Edge Highlights: ARKK, Tesla, Palantir Technologies, Robinhood Markets and Tempus (Zacks)
05:02AM	Tempus to acquire AI digital pathology company Paige (Medical Device Network)
12:21AM	TD Cowen Lifts Tempus AI (TEM) Price Target on Genomic Volumes Growth (Insider Monkey)
Aug-23-25 04:00AM	The Next Big Thing: 2 AI-Powered Healthcare Stocks Ready to Explode (Motley Fool)
Aug-22-25 02:38PM	Tempus AI Expands Into Digital Pathology With Paige Acquisition (Benzinga)
09:20AM	Tempus Announces the Acquisition of Paige (Business Wire)
08:02AM	4 Medical Devices Behemoths to Buy Amid Extensive AI Applications (Zacks)
Aug-21-25 07:11PM	Cathie Wood's ARKK ETF is Back: Buy It or Not? (Zacks)
Aug-20-25 11:47AM	5 High Short-Interest Stocks to Buy Before November (MarketBeat)
Aug-19-25 09:33AM	Strategic Partnerships Power Tempus AI's Healthcare Expansion (Zacks) -6.85%
Aug-18-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +6.33%
Aug-16-25 07:00AM	MarketBeat Week in Review - 08/11 - 08/15 (MarketBeat)
Aug-14-25 02:54PM	Tempus AI Stock Scores Relative Strength Rating Upgrade (Investor's Business Daily)
08:07AM	Webtoon, Carlsberg, Tempus: Trending Stocks (Yahoo Finance Video)
08:00AM	Dow Jones Futures: Is Stock Market Rotating? This Cathie Wood, Nancy Pelosi Pick Is A Buy (Investor's Business Daily)
Aug-13-25 04:39PM	Tempus AI's Strong Q2 Fuels Growth Story-More Upside Ahead? (MarketBeat)
03:00PM	Tempus AI Stock Jumps Post Q2 as EBITDA Breakeven Nears: Buy or Hold? (Zacks)
10:30AM	BC-Most Active Stocks (Associated Press Finance)
08:37AM	TEM Once Again Raises Its 2025 Sales Guidance: What's Driving the Move? (Zacks)
Aug-11-25 10:30AM	BC-Most Active Stocks (Associated Press Finance)
Aug-09-25 03:04AM	Tempus AI Inc (TEM) Q2 2025 Earnings Call Highlights: Record Revenue Growth and Strategic Advances (GuruFocus.com)
Aug-08-25 06:42PM	Why Tempus AI Stock Jumped Today (Motley Fool)
12:19PM	Gold hits new high, altcoins stocks rally, Tempus AI Q2 beat (Yahoo Finance Video)
09:30AM	Compared to Estimates, Tempus (TEM) Q2 Earnings: A Look at Key Metrics (Zacks)
08:47AM	TEM's Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market (Zacks)
07:13AM	Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins (Benzinga)
07:10AM	Tempus AI (TEM) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
06:41AM	Tempus AI shares leap on forecast-beating results, revenue guidance (Investing.com)
06:17AM	Tempus: Q2 Earnings Snapshot (Associated Press Finance)
06:00AM	Tempus Reports Second Quarter 2025 Results (Business Wire)
Aug-07-25 05:35PM	10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates (Zacks) +5.78%
10:51AM	Hims & Hers Redefines Virtual Care With Integrated Tech Platforms (Zacks)

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
VANESSA L KUBO	Officer	Nov 03 '25	Proposed Sale	89.85	20,000	1,797,000		Nov 03 04:26 PM
DAVID R. EPSTEIN	Director	Nov 03 '25	Proposed Sale	89.85	990	88,952		Nov 03 04:25 PM
LEFKOFSKY ERIC P	CEO and Chairman	Oct 28 '25	Sale	89.11	332,500	29,629,006	9,074,532	Oct 30 04:31 PM
Eric Lefkofsky	Officer	Oct 28 '25	Proposed Sale	91.58	332,500	30,450,350		Oct 28 04:09 PM
Fukushima Ryan	Chief Operating Officer	Oct 06 '25	Sale	92.32	5,000	461,606	130,000	Oct 08 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Sep 25 '25	Sale	76.56	332,500	25,457,014	9,141,032	Sep 29 04:33 PM
Eric Lefkofsky	Officer	Sep 25 '25	Proposed Sale	84.13	332,500	27,973,225		Sep 25 07:04 PM
Fukushima Ryan	Chief Operating Officer	Sep 02 '25	Sale	75.80	10,000	758,028	135,000	Sep 04 04:15 PM
Epstein David R	Director	Sep 02 '25	Sale	73.64	250	18,410	27,041	Sep 04 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 27 '25	Sale	74.10	332,500	24,637,581	9,207,533	Aug 29 05:13 PM
Leonsis Theodore	Director	Aug 26 '25	Sale	75.83	20,000	1,516,600	66,756	Aug 28 04:15 PM
Eric Lefkofsky	Officer	Aug 27 '25	Proposed Sale	75.90	332,500	25,236,750		Aug 27 04:19 PM
Leonsis Theodore	Director	Aug 26 '25	Proposed Sale	75.83	20,000	1,516,650		Aug 26 01:27 PM
Polovin Andrew	EVP and General Counsel	Aug 19 '25	Sale	74.65	5,398	402,982	132,056	Aug 21 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Aug 19 '25	Sale	74.65	3,664	273,532	94,115	Aug 21 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Aug 19 '25	Sale	74.65	17,458	1,303,307	2,020,042	Aug 21 04:15 PM
Fukushima Ryan	Chief Operating Officer	Aug 19 '25	Sale	74.65	17,460	1,303,456	839,180	Aug 21 04:15 PM
Rogers James William	Chief Financial Officer	Aug 19 '25	Sale	74.65	7,528	561,994	138,473	Aug 21 04:15 PM
Bartolucci Ryan M	Chief Accounting Officer	Aug 19 '25	Sale	74.65	1,904	142,141	45,895	Aug 21 04:15 PM
Erik Phelps	Officer	Aug 19 '25	Proposed Sale	78.45	3,664	287,441		Aug 20 07:19 AM
Andrew Polovin	Officer	Aug 19 '25	Proposed Sale	78.45	5,398	423,473		Aug 20 07:17 AM
Ryan Fukushima	Officer	Aug 19 '25	Proposed Sale	78.45	17,460	1,369,737		Aug 20 07:15 AM
Eric Paul Lefkofsky	Officer	Aug 19 '25	Proposed Sale	78.45	17,458	1,369,580		Aug 20 07:14 AM
James William Rogers	Officer	Aug 19 '25	Proposed Sale	78.45	7,528	590,572		Aug 19 09:59 PM
Ryan M. Bartolucci	Officer	Aug 19 '25	Proposed Sale	78.45	1,904	149,369		Aug 19 09:56 PM
Leonsis Theodore	Director	Aug 13 '25	Proposed Sale	69.90	44,000	3,075,786		Aug 18 02:44 PM
Leonsis Theodore	Director	Aug 13 '25	Sale	69.90	44,000	3,075,600	86,756	Aug 15 09:21 PM
Epstein David R	Director	Aug 01 '25	Sale	55.16	370	20,409	27,291	Aug 05 04:15 PM
DAVID R. EPSTEIN	Director	Aug 01 '25	Proposed Sale	56.59	620	35,086		Aug 01 04:30 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jul 28 '25	Sale	62.87	166,250	10,452,027	9,274,033	Jul 30 08:42 PM
Eric Lefkofsky	Officer	Jul 28 '25	Proposed Sale	64.49	166,250	10,721,462		Jul 28 04:13 PM
Fukushima Ryan	Chief Operating Officer	Jul 07 '25	Sale	60.00	5,000	300,000	145,000	Jul 09 04:15 PM
VANESSA L KUBO	Officer	Jul 07 '25	Proposed Sale	60.97	20,000	1,219,400		Jul 07 04:16 PM
Doudna Jennifer A	Director	Jul 01 '25	Sale	62.52	625	39,075	26,554	Jul 03 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 17 '25	Sale	70.07	250,000	17,516,593	9,357,283	Jun 20 04:15 PM
LEFKOFSKY ERIC P	CEO and Chairman	Jun 18 '25	Sale	69.44	250,000	17,359,469	9,307,283	Jun 20 04:15 PM
Phelps Erik	EVP & Chief Admin & Legal Off	Jun 16 '25	Sale	72.56	51,317	3,723,634	97,779	Jun 18 04:15 PM
Polovin Andrew	EVP and General Counsel	Jun 16 '25	Sale	72.13	1,423	102,641	137,454	Jun 18 04:15 PM
Eric Paul Lefkofsky	Officer	Jun 17 '25	Proposed Sale	72.00	400,000	28,800,000		Jun 17 09:45 PM
ERIK PHELPS	Officer	Jun 16 '25	Proposed Sale	71.28	51,317	3,657,876		Jun 16 04:30 PM
ANDREW POLOVIN	Officer	Jun 16 '25	Proposed Sale	71.28	1,423	101,431		Jun 16 04:22 PM
Leonsis Theodore	Director	Jun 11 '25	Sale	67.66	205,847	13,927,976	0	Jun 13 04:15 PM
Revolution Growth Management C	Shareholder	Jun 11 '25	Proposed Sale	69.38	205,847	14,281,665		Jun 11 04:02 PM
Fukushima Ryan	Chief Operating Officer	Jun 03 '25	Sale	62.29	20,000	1,245,764	856,640	Jun 05 04:15 PM
Doudna Jennifer A	Director	Jun 02 '25	Sale	55.20	558	30,802	27,179	Jun 04 04:15 PM
Epstein David R	Director	Jun 02 '25	Sale	55.20	250	13,800	27,661	Jun 04 04:15 PM
JENNIFER A DOUDNA	Director	Jun 02 '25	Proposed Sale	55.18	1,183	65,278		Jun 02 04:32 PM
Rogers James William	Chief Financial Officer	May 20 '25	Sale	63.27	23,121	1,462,809	146,001	May 22 08:00 PM
Polovin Andrew	EVP and General Counsel	May 20 '25	Sale	63.43	17,552	1,113,385	138,877	May 22 08:00 PM
Phelps Erik	EVP & Chief Admin & Legal Off	May 20 '25	Sale	63.21	8,415	531,918	149,096	May 22 08:00 PM
LEFKOFSKY ERIC P	CEO and Chairman	May 20 '25	Sale	63.21	16,752	1,058,905	4,878,837	May 22 08:00 PM
Fukushima Ryan	Chief Operating Officer	May 20 '25	Sale	63.21	7,820	494,308	876,640	May 22 08:00 PM
Bartolucci Ryan M	Chief Accounting Officer	May 20 '25	Sale	63.23	6,073	384,023	47,799	May 22 08:00 PM
Ryan M. Bartolucci	Officer	May 20 '25	Proposed Sale	63.74	4,254	271,150		May 21 07:39 PM
Ryan Fukushima	Officer	May 20 '25	Proposed Sale	63.74	7,820	498,447		May 21 07:36 PM
Andrew Polovin	Officer	May 20 '25	Proposed Sale	63.74	9,797	624,461		May 21 07:25 PM
Eric Paul Lefkofsky	Officer	May 20 '25	Proposed Sale	63.74	16,752	1,067,772		May 21 07:23 PM
Erik Phelps	Officer	May 20 '25	Proposed Sale	63.74	8,415	536,372		May 21 07:20 PM
James William Rogers	Officer	May 20 '25	Proposed Sale	63.74	11,413	727,465		May 21 07:18 PM
RYAN BARTOLUCCI	Officer	May 20 '25	Proposed Sale	63.74	1,819	115,943		May 20 04:32 PM
ANDREW POLOVIN	Officer	May 20 '25	Proposed Sale	63.74	7,755	494,304		May 20 04:31 PM
JAMES ROGERS	Officer	May 20 '25	Proposed Sale	63.74	11,708	746,268		May 20 04:31 PM
Leonsis Theodore	Director	May 09 '25	Sale	66.26	770	51,020	43,550	May 13 04:15 PM
REVOLUTION GROWTH III, LP	Shareholder	May 09 '25	Proposed Sale	65.22	770	50,219		May 09 04:18 PM
Fukushima Ryan	Chief Operating Officer	May 06 '25	Sale	52.36	20,000	1,047,239	884,460	May 08 04:30 PM
Epstein David R	Director	May 01 '25	Sale	53.50	370	19,795	25,914	May 05 04:15 PM
Gottlieb Scott	Director	Apr 01 '25	Sale	47.21	27,837	1,314,154	32,839	Apr 03 05:30 PM
Doudna Jennifer A	Director	Apr 01 '25	Sale	48.12	625	30,075	25,740	Apr 03 04:15 PM
Fukushima Ryan	Chief Operating Officer	Apr 01 '25	Sale	47.20	20,000	944,085	904,460	Apr 03 04:15 PM
Frederick Wayne A.I.	Director	Mar 31 '25	Sale	45.54	3,000	136,620	26,514	Apr 02 06:13 PM
RYAN FUKUSHIMA	Officer	Apr 01 '25	Proposed Sale	48.24	60,000	2,894,400		Apr 01 04:22 PM
Polovin Andrew	EVP and General Counsel	Mar 21 '25	Sale	50.00	3,076	153,800	151,095	Mar 25 04:15 PM
ANDREW POLOVIN	Officer	Mar 21 '25	Proposed Sale	48.04	3,076	147,771		Mar 21 04:21 PM
Rogers James William	Chief Financial Officer	Mar 18 '25	Sale	45.97	23,030	1,058,699	164,750	Mar 19 06:30 PM
Polovin Andrew	EVP and General Counsel	Mar 18 '25	Sale	45.98	13,135	603,970	154,171	Mar 19 06:30 PM
Epstein David R	Director	Mar 17 '25	Sale	46.83	990	46,362	26,284	Mar 19 06:30 PM
West Nadja	Director	Mar 17 '25	Sale	48.86	7,634	372,962	30,071	Mar 19 06:30 PM
Gottlieb Scott	Director	Mar 17 '25	Sale	48.85	27,838	1,359,989	60,676	Mar 19 06:30 PM
Frederick Wayne A.I.	Director	Mar 17 '25	Sale	48.85	9,000	439,659	29,514	Mar 19 06:30 PM
Doudna Jennifer A	Director	Mar 17 '25	Sale	48.80	9,308	454,210	26,365	Mar 19 06:30 PM
ANDREW POLOVIN	Officer	Mar 18 '25	Proposed Sale	49.87	13,135	655,042		Mar 18 04:41 PM
JAMES ROGERS	Officer	Mar 18 '25	Proposed Sale	49.87	23,030	1,148,506		Mar 18 04:27 PM
WAYNE FREDERICK	Director	Mar 17 '25	Proposed Sale	47.17	12,000	566,040		Mar 17 04:47 PM
DAVID R. EPSTEIN	Director	Mar 17 '25	Proposed Sale	47.17	1,610	75,944		Mar 17 04:25 PM
SCOTT GOTTLIEB	Director	Mar 17 '25	Proposed Sale	47.17	55,675	2,626,190		Mar 17 04:23 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 05 '25	Sale	50.93	562,345	28,641,725	9,457,283	Mar 07 04:56 PM
LEFKOFSKY ERIC P	CEO and Chairman	Mar 06 '25	Sale	49.83	250,000	12,457,454	9,407,283	Mar 07 04:56 PM
Fukushima Ryan	Chief Operating Officer	Mar 04 '25	Sale	51.15	20,000	1,022,974	924,460	Mar 06 05:05 PM
West Nadja	Director	Mar 04 '25	Sale	51.11	809	41,347	37,705	Mar 06 05:05 PM
Eric P. Lefkofsky	Officer	Mar 05 '25	Proposed Sale	52.73	662,345	34,925,452		Mar 05 05:44 PM
Doudna Jennifer A	Director	Mar 03 '25	Sale	57.52	338	19,442	35,673	Mar 05 04:15 PM
Epstein David R	Director	Mar 03 '25	Sale	57.52	250	14,380	27,274	Mar 05 04:15 PM
NADJA WEST	Director	Mar 04 '25	Proposed Sale	50.93	8,443	430,002		Mar 04 05:08 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 27 '25	Sale	58.75	3,240,234	190,363,748	0	Feb 27 07:39 PM
Lightbank Investments 1B, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	115,751	6,840,884		Feb 27 04:27 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,580,928	93,432,845		Feb 27 04:26 PM
Lightbank Global, LLC	Affiliate	Feb 27 '25	Proposed Sale	59.10	1,397,589	82,597,510		Feb 27 04:25 PM
Innovation Group Investors, L.	Affiliate	Feb 27 '25	Proposed Sale	59.10	145,966	8,626,591		Feb 27 04:24 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 19 '25	Sale	80.87	84,640	6,844,680	4,964,820	Feb 20 07:55 PM
LEFKOFSKY ERIC P	CEO and Chairman	Feb 20 '25	Sale	74.09	69,231	5,129,325	4,895,589	Feb 20 07:55 PM

Open in Screener

PODD

Insulet Corporation

Nov 04 • 12:35PM ET

319.69

+0.92 0.29 %

Healthcare • Medical Devices • USA • NASD

PODD Insulet Corporation daily Stock Chart

Peers: DXCM JNJ ABT MDT EW SYK TNDM BSX BAX LIVN

| Held by: VTI VOO IVV SPY VB VO VUG XLV IWP VBK

Index	S&P 500	P/E	97.29	EPS (ttm)	3.29	Insider Own	0.45%	Shs Outstand	70.39M	Perf Week	-1.43%
Market Cap	22.50B	Forward P/E	54.57	EPS next Y	5.86	Insider Trans	-7.24%	Shs Float	70.07M	Perf Month	2.57%
Enterprise Value	22.80B	PEG	3.07	EPS next Q	1.14	Inst Own	102.25%	Short Float	2.30%	Perf Quarter	15.29%
Income	236.10M	P/S	9.54	EPS this Y	44.07%	Inst Trans	-1.48%	Short Ratio	2.63	Perf Half Y	23.49%
Sales	2.36B	P/B	15.38	EPS next Y	25.51%	ROA	7.44%	Short Interest	1.61M	Perf YTD	22.45%
Book/sh	20.78	P/C	20.06	EPS next 5Y	31.71%	ROE	19.18%	52W High	353.50 -9.56%	Perf Year	38.08%
Cash/sh	15.93	P/FCF	56.93	EPS past 3/5Y	186.88% 98.82%	ROIC	9.83%	52W Low	230.05 38.97%	Perf 3Y	25.10%
Dividend Est.	-	EV/EBITDA	44.77	Sales past 3/5Y	23.54% 22.92%	Gross Margin	71.48%	Volatility	2.34% 2.37%	Perf 5Y	39.96%
Dividend TTM	-	EV/Sales	9.66	EPS Y/Y TTM	-40.46%	Oper. Margin	17.26%	ATR (14)	7.95	Perf 10Y	978.94%
Dividend Ex-Date	-	Quick Ratio	1.79	Sales Y/Y TTM	25.99%	Profit Margin	10.01%	RSI (14)	49.70	Recom	1.48
Dividend Gr. 3/5Y	- -	Current Ratio	2.23	EPS Q/Q	-87.70%	SMA20	0.06%	Beta	1.38	Target Price	365.78
Payout	0.00%	Debt/Eq	0.97	Sales Q/Q	32.88%	SMA50	-1.93%	Rel Volume	0.52	Prev Close	318.77
Employees	3900	LT Debt/Eq	0.64	Earnings	Nov 06 BMO	SMA200	8.04%	Avg Volume	612.17K	Price	319.69
IPO	May 15, 2007	Option/Short	Yes / Yes	EPS/Sales Surpr.	27.20% 5.68%	Trades		Volume	158,520	Change	0.29%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-21-25	Resumed	Stifel	Buy	$370
Sep-08-25	Resumed	Oppenheimer	Outperform	$365
Jun-16-25	Initiated	Truist	Buy	$365
May-30-25	Initiated	Goldman	Buy	$380
May-13-25	Upgrade	Wolfe Research	Peer Perform → Outperform	$350
Apr-29-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Mar-06-25	Initiated	RBC Capital Mkts	Outperform	$340
Nov-06-24	Initiated	Bernstein	Outperform	$300
May-30-24	Initiated	Redburn Atlantic	Buy	$235
May-07-24	Upgrade	Wolfe Research	Peer Perform → Outperform	$200
Dec-21-23	Upgrade	Robert W. Baird	Neutral → Outperform	$180 → $238
Dec-04-23	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$185 → $234
Oct-02-23	Upgrade	Jefferies	Hold → Buy	$260 → $240
Aug-21-23	Upgrade	Citigroup	Neutral → Buy	$273 → $265
Aug-21-23	Downgrade	Robert W. Baird	Outperform → Neutral	$320 → $219
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$343
Jan-26-23	Initiated	Wolfe Research	Peer Perform
Nov-04-22	Upgrade	Piper Sandler	Neutral → Overweight	$235 → $340
Oct-18-22	Initiated	Barclays	Equal Weight	$238
Oct-12-22	Initiated	Jefferies	Hold	$260

Show Previous Ratings

Today 09:15AM	Ahead of Insulet (PODD) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics (Zacks)
Nov-03-25 12:08PM	Can Strength in Rental Business Drive INFU Stock Before Q3 Earnings? (Zacks)
Oct-31-25 10:17AM	EW Stock Gains on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
09:57AM	Analyst Report: DexCom, Inc. (Morningstar Research)
09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
12:24PM	Loading…
Oct-30-25 12:24PM	ALGN Stock Up on Q3 Earnings and Revenue Beat, Margins Crash (Zacks)
10:00AM	Insulet (PODD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
09:31AM	RBC Capital Lifts Insulet (PODD) PT to $365 on Strong Momentum, Q3 Guidance Optimism (Insider Monkey)
04:00AM	Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month (Business Wire)
Oct-29-25 09:08AM	CHE Stock Falls on Q3 Earnings and Revenue Miss, Margins Crash (Zacks)
Oct-28-25 10:36AM	Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption? (Zacks)
10:01AM	LH Q3 Earnings Beat, Revenues Miss, '25 Sales View Cut, Stock Down (Zacks)
Oct-24-25 01:53PM	ITGR Shares Down Despite Q3 Earnings & Revenues Beat Estimates (Zacks)
08:47AM	What to Expect From Insulet's Next Quarterly Earnings Report (Barchart)
Oct-23-25 07:00AM	Insulet Announces Appointment of Robert L. Huffines to its Board of Directors (Business Wire)
10:56AM	Loading…
Oct-22-25 10:56AM	ISRG Stock Gains on Q3 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
09:23AM	Boston Scientific Beats on Q3 Earnings, Raises 2025 View, Stock Up (Zacks)
09:16AM	Thermo Fisher's Q3 Earnings & Revenues Top Estimates, Stock Climbs (Zacks)
Oct-21-25 11:27AM	Stifel resumes coverage on medtech names, sees long-term diabetes devices growth (Investing.com)
09:29AM	Quest Diagnostics Stock Up on Q3 Earnings & Revenue Beat, Margins Rise (Zacks)
Oct-20-25 06:30AM	Insulet Corporation (PODD) Sees Higher 2025-2026 Revenue and Operating Margins, Says Canaccord (Insider Monkey)
Oct-15-25 10:12AM	Abbott's Q3 Earnings Meet Estimates, Revenues Up Y/Y, Stock Climbs (Zacks)
Oct-14-25 03:23PM	TransMedics Group Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
Oct-10-25 08:39AM	Neogen Q1 Earnings Miss Estimates, Revenues Beat, Stock Climbs (Zacks)
07:00AM	Insulet to Host Investor Day on November 20, 2025 (Business Wire)
Oct-08-25 01:47AM	Truist Securities Reiterates Buy Rating on Insulet (PODD) Stock (Insider Monkey)
Oct-07-25 12:45PM	Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes" (Zacks)
Oct-01-25 07:51PM	Canaccord Genuity Raises Price Target on Insulet Corporation (PODD) to $399, Maintains Buy Rating (Insider Monkey)
01:56PM	Insulet Corporation (PODD) Q2 Revenue Surges 32.9% to $649M, Raises Full-Year Guidance (Insider Monkey)
Sep-29-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
08:22AM	Loading…
Sep-26-25 08:22AM	Insulet Stock Surges 37.4% in 12 months: What's Driving the Rally? (Zacks)
Sep-24-25 07:08AM	Is Insulet Stock Outperforming the S&P 500? (Barchart)
Sep-19-25 06:59PM	Analyst Report: DexCom, Inc. (Morningstar Research)
Sep-18-25 01:10PM	Insulet gets artistic with Omnipod Mango Pantone colour creation (Medical Device Network)
08:51AM	Insulet Corporation (PODD) Benefited from Omnipod Sales (Insider Monkey)
07:00AM	Insulet and Pantone Partner to Launch Omnipod Mango in Vibrant New Palette (Business Wire)
Sep-17-25 01:35PM	Why Insulet (PODD) Shares Are Falling Today (StockStory)
Sep-16-25 07:36AM	Insulet names new CFO; Dexcom CEO on leave (MedTech Dive)
07:00AM	Insulet Announces CFO Transition (Business Wire)
Sep-15-25 09:50AM	Here's Why Insulet (PODD) is a Strong Momentum Stock (Zacks)
Sep-12-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
12:01AM	3 Reasons Investors Love Insulet (PODD) (StockStory)
Sep-09-25 12:34AM	3 S&P 500 Stocks to Target This Week (StockStory)
Sep-08-25 12:50PM	Oppenheimer sees stronger growth at Boston Scientific (Investing.com)
Aug-29-25 08:00AM	Omnipod Maker Insulet Is In A Buy Zone As Its Market Expands To Millions (Investor's Business Daily)
Aug-27-25 09:45AM	Here's Why Insulet (PODD) is a Strong Growth Stock (Zacks)
Aug-26-25 11:13AM	Insulet promotes Eric Benjamin to chief operating officer (MedTech Dive)
08:34AM	Insulet Stock: Analyst Estimates & Ratings (Barchart)
Aug-25-25 11:35PM	Patient Monitoring Stocks Q2 Highlights: Insulet (NASDAQ:PODD) (StockStory)
05:00PM	Insulet Elevates Eric Benjamin to Chief Operating Officer (Business Wire)
09:50AM	Why Insulet (PODD) is a Top Momentum Stock for the Long-Term (Zacks)
Aug-22-25 09:55AM	Insulet Gains 77.2% in a Year: What's Driving the Rally? (Zacks)
Aug-21-25 02:03PM	Edwards Lifesciences Stock Pumps Up Its Relative Strength Rating (Investor's Business Daily)
Aug-20-25 01:11PM	Omnipod Maker Hit A Buy Point. Here's Where To Pick Up Shares. (Investor's Business Daily)
Aug-19-25 04:35PM	Insulet Stock Breaks Out Again As Momentum Continues (Investor's Business Daily)
02:21PM	Final Trades: Rocket Companies, Cisco Systems, Insulet Corp and the IGV (CNBC TV)
06:00AM	Insulet to Participate in Upcoming Investor Conferences (Business Wire)
Aug-14-25 04:54PM	Stock Market Today: Indexes Mixed; Coherent Hits 3 Sell Signals But New IPO Bullish Jumps 10%; 3 Growth Stocks Set Up Entries (Investor's Business Daily)
03:15PM	Stock Market Today: Dow And Nasdaq Edge Lower As AI Stock Coherent Hits 3 Sell Signals; 3 Growth Stocks Set Up Entries (Live) (Investor's Business Daily)
01:34AM	The Top 5 Analyst Questions From Insulet's Q2 Earnings Call (StockStory)
Aug-12-25 11:40PM	PODD Q2 Deep Dive: Omnipod 5 Adoption and International Expansion Drive Results (StockStory)
08:25AM	Insulet Q2 Earnings & Revenues Beat Estimates, Stock Up, Margins Rise (Zacks)
Aug-11-25 09:45AM	Why Insulet (PODD) is a Top Growth Stock for the Long-Term (Zacks)
Aug-08-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
05:16AM	Tandem, Insulet monitoring CMS payment proposal for diabetes tech (MedTech Dive)
Aug-07-25 05:23PM	S&P 500 Gains and Losses Today: Apple Stock Climbs; Eli Lilly Slumps After Disappointing Trial Results (Investopedia) +9.47%
04:18PM	Insulet Pops As Diabetes Medtech Continues Its Streak Of 'Impressive Beat-And-Raises' (Investor's Business Daily)
02:01PM	Insulet (NASDAQ:PODD) Beats Expectations in Strong Q2, Stock Soars (StockStory)
01:50PM	Insulet Peer Tandem Diabetes Underwhelming Earnings, Dull Outlook Drags Stock (Benzinga)
12:06PM	Analyst Report: Insulet Corporation (Morningstar Research)
09:30AM	Insulet (PODD) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:15AM	Insulet (PODD) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
07:13AM	Insulet: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Insulet Reports Second Quarter 2025 Revenue Increase of 32.9% Year-Over-Year (31.3% Constant Currency1) (Business Wire)
Aug-05-25 11:07PM	Insulet (PODD) Q2 Earnings: What To Expect (StockStory)
09:15AM	Curious about Insulet (PODD) Q2 Performance? Explore Wall Street Estimates for Key Metrics (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Jul-31-25 04:26PM	Analyst Report: DexCom, Inc. (Morningstar Research)
10:00AM	Insulet (PODD) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-30-25 10:30AM	QualiZeal Welcomes Healthcare Industry Visionary Dr. Aiman Abdel-Malek to Business Advisory Board (Business Wire)
Jul-24-25 08:14AM	What to Expect From Insulet's Q2 2025 Earnings Report (Barchart)
Jul-11-25 08:12PM	Analyst Report: Insulet Corporation (Morningstar Research)
Jul-09-25 02:33PM	Semler Scientific Stock Gets Relative Strength Rating Upgrade (Investor's Business Daily)
12:10PM	Will Insulet (PODD) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jul-08-25 06:00AM	Insulet to Announce Second Quarter 2025 Financial Results on August 7, 2025 (Business Wire)
Jul-01-25 04:04PM	Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids (Investor's Business Daily)
12:16PM	Apple AI, Wolfspeed bankruptcy, medical device stocks (Yahoo Finance Video)
09:59AM	Medical device maker stocks falls after proposed Medicare payment cuts (Investing.com)
Jun-30-25 06:19AM	5 Insightful Analyst Questions From Insulet's Q1 Earnings Call (StockStory)
Jun-28-25 09:10AM	10 Under-the-Radar Healthcare Stocks With Incredible Growth Potential (Motley Fool)
Jun-25-25 12:15PM	Diabetes stocks rally after RFK comments on HHS campaign (TipRanks)
Jun-24-25 08:54AM	How Is Insulet's Stock Performance Compared to Other Medical Devices Stocks? (Barchart)
Jun-19-25 06:00AM	Insulet to Share Additional Evidence Demonstrating the Impact of Omnipod 5 on Improved Health Outcomes at the American Diabetes Association 85th Scientific Sessions (Business Wire)
Jun-17-25 09:35AM	Cisco upgraded, CoreWeave downgraded: Wall Streets top analyst calls (TipRanks)
Jun-16-25 10:21AM	Truist starts on diabetes device makers, sees glucose monitor, insulin pump growth (Investing.com)
Jun-11-25 09:51AM	Here's Why You Should Retain PODD Stock in Your Portfolio Now (Zacks)
Jun-10-25 08:30AM	Insulets Omnipod 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users (Business Wire)
04:36AM	PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption (StockStory)
Jun-09-25 07:29AM	3 Medical Technology Stocks Outperforming in 2025 (MarketBeat)
Jun-06-25 04:08PM	Healthcare companies are hiring. Is it time to look for growth stocks in this beaten-down sector? (MarketWatch)

Insulet Corp. is a medical device company, which engages in the development, manufacture, and marketing of an insulin infusion system for people with insulin-dependent diabetes. It specializes in diabetes supplies, including the OmniPod System, as well as other diabetes related products and supplies such as blood glucose testing supplies, traditional insulin pumps, pump supplies, and pharmaceuticals. The company was founded by John L. Brooks III and John T. Garibotto in July 2000 and is headquartered in Acton, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Manea Dan	Former Officer	Sep 16 '25	Proposed Sale	337.73	1,347	454,920		Sep 16 01:21 PM
Singh Prem	SVP, Global Operations	Sep 08 '25	Sale	347.49	687	238,726	3,456	Sep 09 04:19 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Option Exercise	241.10	797	192,160	4,687	Sep 09 04:16 PM
Cousin Laetitia	SVP, Reg, Quality & Compliance	Sep 08 '25	Sale	348.81	797	278,002	3,890	Sep 09 04:16 PM
Cousin Laetitia	Officer	Sep 08 '25	Proposed Sale	348.81	797	278,000		Sep 08 02:07 PM
Singh Prem	Officer	Sep 08 '25	Proposed Sale	347.48	687	238,718		Sep 08 01:31 PM
Benjamin Eric	EVP, CPXO	Aug 21 '25	Sale	332.23	4,263	1,416,296	16,736	Aug 22 04:16 PM
Benjamin Eric	Officer	Aug 21 '25	Proposed Sale	332.23	4,263	1,416,296		Aug 21 10:21 AM
Singh Prem	SVP, Global Operations	Aug 07 '25	Option Exercise	271.28	1,343	364,325	5,486	Aug 08 04:03 PM
Singh Prem	SVP, Global Operations	Aug 07 '25	Sale	320.00	1,343	429,760	4,143	Aug 08 04:03 PM
Singh Prem	Officer	Aug 07 '25	Proposed Sale	320.00	1,343	429,760		Aug 07 11:35 AM
Singh Prem	SVP, Global Operations	Jun 13 '25	Option Exercise	166.62	1,257	209,441	6,470	Jun 16 04:18 PM
Singh Prem	SVP, Global Operations	Jun 13 '25	Sale	300.05	2,327	698,216	4,143	Jun 16 04:18 PM
Manea Dan	SVP, Chief HR Officer	Jun 13 '25	Sale	300.05	1,300	390,065	9,090	Jun 16 04:16 PM
Singh Prem	Officer	Jun 13 '25	Proposed Sale	300.05	2,327	698,216		Jun 13 10:15 AM
Manea Dan	Officer	Jun 13 '25	Proposed Sale	300.05	1,300	390,065		Jun 13 09:45 AM
BORIO LUCIANA	Director	Jun 09 '25	Sale	305.73	481	147,056	3,087	Jun 10 04:17 PM
BORIO LUCIANA	Director	Jun 09 '25	Proposed Sale	305.72	481	147,054		Jun 09 01:08 PM
Hollingshead James	Former Officer	May 16 '25	Proposed Sale	323.10	15,605	5,041,964		May 16 04:40 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Option Exercise	95.43	5,278	503,680	28,458	May 15 04:25 PM
Kapples John W.	SVP and General Counsel	May 14 '25	Sale	318.47	5,278	1,680,885	23,180	May 15 04:25 PM
Hopfield Jessica	Director	May 13 '25	Option Exercise	28.87	5,235	151,134	32,152	May 14 04:15 PM
Hopfield Jessica	Director	May 13 '25	Sale	317.54	5,235	1,662,322	26,917	May 14 04:15 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Option Exercise	92.11	3,001	276,422	23,907	May 14 04:08 PM
Benjamin Eric	EVP, CPXO	May 13 '25	Sale	320.00	3,001	960,320	20,906	May 14 04:08 PM
Kapples John W.	Officer	May 14 '25	Proposed Sale	318.47	5,278	1,680,901		May 14 12:32 PM
Field Mark N	Former Officer	May 13 '25	Proposed Sale	321.31	2,457	789,459		May 13 01:44 PM
Benjamin Eric	Officer	May 13 '25	Proposed Sale	320.00	3,001	960,320		May 13 12:51 PM
Hopfield Jessica	Director	May 13 '25	Proposed Sale	317.54	5,235	1,662,322		May 13 10:19 AM
Frederick Wayne A.I.	Director	Mar 25 '25	Sale	275.00	1,825	501,875	3,231	Mar 26 04:22 PM
Frederick Wayne A.I.	Director	Mar 25 '25	Proposed Sale	275.00	1,825	501,875		Mar 25 10:30 AM
Benjamin Eric	EVP, CPXO	Mar 03 '25	Option Exercise	56.52	5,146	290,873	20,906	Mar 04 04:09 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Option Exercise	65.00	5,075	329,898	23,777	Jan 22 04:10 PM
Benjamin Eric	EVP, CPXPO	Jan 21 '25	Sale	280.00	12,394	3,470,320	11,383	Jan 22 04:10 PM
Benjamin Eric	Officer	Jan 21 '25	Proposed Sale	280.00	12,394	3,470,320		Jan 21 10:56 AM
Benjamin Eric	EVP, CPXPO	Dec 16 '24	Sale	267.60	4,362	1,167,271	18,702	Dec 17 04:14 PM
Benjamin Eric	Officer	Dec 16 '24	Proposed Sale	267.60	4,362	1,167,271		Dec 16 10:38 AM
Budden Lauren	Group VP, CAO and Controller	Dec 10 '24	Sale	275.62	915	252,192	5,733	Dec 11 04:00 PM
Budden Lauren	Officer	Dec 10 '24	Proposed Sale	275.62	915	252,194		Dec 10 05:18 PM
BORIO LUCIANA	Director	Nov 12 '24	Sale	274.80	508	139,598	2,790	Nov 13 04:01 PM
BORIO LUCIANA	Director	Nov 12 '24	Proposed Sale	274.81	508	139,602		Nov 12 04:01 PM

Open in Screener

WDAY

Workday Inc

Nov 04 • 12:35PM ET

232.94

-4.74 -2.00 %

Technology • Software - Application • USA • NASD

Peers: MSFT CRM ADBE ORCL NOW SAP INTU PAYC TEAM ZS

| Held by: VTI VOO QQQ VUG IVV SPY XLK VGT MOAT IWF

Index	NDX, S&P 500	P/E	107.73	EPS (ttm)	2.16	Insider Own	19.40%	Shs Outstand	216.90M	Perf Week	-1.69%
Market Cap	62.19B	Forward P/E	21.99	EPS next Y	10.59	Insider Trans	-1.55%	Shs Float	215.20M	Perf Month	-2.28%
Enterprise Value	57.78B	PEG	5.04	EPS next Q	2.17	Inst Own	74.07%	Short Float	4.63%	Perf Quarter	1.68%
Income	583.00M	P/S	6.97	EPS this Y	21.86%	Inst Trans	-0.67%	Short Ratio	3.11	Perf Half Y	-5.99%
Sales	8.93B	P/B	6.78	EPS next Y	19.06%	ROA	3.41%	Short Interest	9.96M	Perf YTD	-9.73%
Book/sh	34.36	P/C	7.59	EPS next 5Y	21.39%	ROE	6.66%	52W High	294.00 -20.77%	Perf Year	-0.39%
Cash/sh	30.68	P/FCF	25.98	EPS past 3/5Y	156.63% -	ROIC	4.54%	52W Low	205.33 13.44%	Perf 3Y	47.75%
Dividend Est.	-	EV/EBITDA	52.86	Sales past 3/5Y	17.81% 18.37%	Gross Margin	75.48%	Volatility	3.10% 2.90%	Perf 5Y	11.08%
Dividend TTM	-	EV/Sales	6.47	EPS Y/Y TTM	-62.56%	Oper. Margin	8.47%	ATR (14)	6.97	Perf 10Y	201.73%
Dividend Ex-Date	-	Quick Ratio	2.05	Sales Y/Y TTM	14.21%	Profit Margin	6.53%	RSI (14)	46.08	Recom	1.63
Dividend Gr. 3/5Y	- -	Current Ratio	2.05	EPS Q/Q	71.32%	SMA20	-1.85%	Beta	1.14	Target Price	281.39
Payout	0.00%	Debt/Eq	0.41	Sales Q/Q	12.66%	SMA50	-0.80%	Rel Volume	0.43	Prev Close	237.68
Employees	20400	LT Debt/Eq	0.40	Earnings	Aug 21 AMC	SMA200	-3.70%	Avg Volume	3.20M	Price	232.94
IPO	Oct 12, 2012	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.50% 0.28%	Trades		Volume	687,186	Change	-2.00%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-17-25	Upgrade	Piper Sandler	Underweight → Neutral	$235
Sep-17-25	Upgrade	Guggenheim	Neutral → Buy	$285
Aug-22-25	Reiterated	Oppenheimer	Outperform	$300 → $270
Aug-22-25	Reiterated	BMO Capital Markets	Outperform	$314 → $285
Aug-14-25	Initiated	Cantor Fitzgerald	Overweight	$265
Jul-10-25	Downgrade	Piper Sandler	Neutral → Underweight	$235
Feb-27-25	Reiterated	BMO Capital Markets	Outperform	$300 → $314
Feb-19-25	Initiated	Redburn Atlantic	Neutral
Feb-19-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$330 → $275
Jan-08-25	Upgrade	Deutsche Bank	Hold → Buy	$265 → $300
Jan-06-25	Upgrade	Guggenheim	Sell → Neutral
Nov-27-24	Downgrade	Piper Sandler	Overweight → Neutral	$285 → $270
Nov-19-24	Initiated	Scotiabank	Sector Outperform	$340
May-24-24	Reiterated	BMO Capital Markets	Outperform	$338 → $300
Feb-27-24	Reiterated	Needham	Buy	$300 → $350
Jan-10-24	Resumed	DA Davidson	Neutral	$300
Jan-04-24	Resumed	KeyBanc Capital Markets	Overweight	$310
Nov-29-23	Reiterated	BMO Capital Markets	Outperform	$260 → $290
Aug-25-23	Reiterated	Needham	Buy	$220 → $250
Jun-28-23	Initiated	RBC Capital Mkts	Outperform	$275

Show Previous Ratings

Today 09:15AM	Workday Completes Acquisition of Sana (PR Newswire)
08:30AM	Workday to Announce Fiscal 2026 Third Quarter Financial Results on November 25, 2025 (PR Newswire)
12:03AM	Insperity Inc (NSP) Q3 2025 Earnings Call Highlights: Strong Client Retention Amidst Rising ... (GuruFocus.com)
Nov-03-25 12:10PM	Will Workday (WDAY) Beat Estimates Again in Its Next Earnings Report? (Zacks)
11:43AM	PINS Set to Report Q3 Results: Will Revenue Growth Boost Earnings? (Zacks)
11:36AM	Loading…
11:36AM	AKAM Set to Report Q3 Results: Will Top-Line Growth Boost Earnings? (Zacks)
Oct-31-25 09:30AM	Workday (WDAY) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
Oct-30-25 06:01AM	Metro Bank selects Infosys and Workday to transform finance operations (Retail Banker International)
Oct-29-25 05:50PM	Workday (WDAY) Stock Moves -2.35%: What You Should Know (Zacks)
11:14AM	Workday Recognized as a Leader in Inaugural Gartner Magic Quadrant for Cloud ERP Finance (PR Newswire)
08:10AM	Buy 5 AI Laggards of 2025 to Tap Astonishing Growth Potential (Zacks)
Oct-28-25 09:45AM	Here's Why Workday (WDAY) is a Strong Growth Stock (Zacks)
09:13AM	What to Expect From Workday's Next Quarterly Earnings Report (Barchart)
08:50AM	Why Investors Need to Take Advantage of These 2 Computer and Technology Stocks Now (Zacks)
Oct-27-25 02:10PM	IDCC Set to Report Q3 Results: Will Revenue Growth Boost Earnings? (Zacks)
10:00AM	Loading…
Oct-26-25 10:00AM	AI will 'amplify, not replace' human performance: Workday CEO (Yahoo Finance Video)
Oct-25-25 08:00AM	Top execs share their best career advice for Gen Z (Fortune)
Oct-24-25 07:00AM	Bear of the Day: Paycom Software (PAYC) (Zacks)
Oct-23-25 12:40AM	3 Volatile Stocks We Think Twice About (StockStory)
Oct-22-25 03:40PM	Workday CEO talks new AI model tools for businesses (Yahoo Finance Video)
02:56PM	Workday Doubles Down on AI (Bloomberg)
01:42PM	Workday wants to buy into the AI boom without overpaying (Yahoo Finance)
01:05PM	Why CIOs and CFOs are becoming attached at the hip as businesses make big AI investments (Fortune)
12:45PM	Workday's agentic AI will save more time for your business: CEO (Yahoo Finance Video)
09:15AM	Workday Introduces New Custom AI Model Library to Power Smarter, Faster Contract Reviews (PR Newswire)
Oct-21-25 08:50AM	These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
Oct-20-25 09:05AM	MSI Advances AI Native Public Safety Solution: Will it Boost Prospects? (Zacks)
Oct-18-25 08:00AM	5 bubble-resistant tech stocks to guard your portfolio from an AI crash (MarketWatch)
Oct-17-25 12:25PM	1 Cash-Producing Stock to Own for Decades and 2 We Brush Off (StockStory)
09:43AM	Stock Market Today: Dow Up Amid Bank Fears; Eli Lilly, Novo Sell Off On Trump Comments (Live Coverage) (Investor's Business Daily)
11:44AM	Loading…
Oct-15-25 11:44AM	Workday Recognized as a Leader in 2025 Gartner Magic Quadrant for Cloud ERP for Service-Centric Enterprises for Fourth Consecutive Year (PR Newswire)
09:00AM	Workday's Higher Education Momentum Accelerates as Over 650 Institutions Worldwide Turn to AI to Navigate Uncertainty and Transform the Student Experience (PR Newswire)
08:27AM	NetApp Launches Enterprise-Grade Data Platform to Power AI Innovation (Zacks)
05:10AM	Workday Adds to AI Push With $200 Million Investment in Irish Innovation Center (The Wall Street Journal)
Oct-13-25 05:50PM	Here's Why Workday (WDAY) Gained But Lagged the Market Today (Zacks)
02:24PM	ServiceNow Drops 16% Year to Date: Should You Still Buy the Stock? (Zacks)
Oct-12-25 08:41AM	Workday Inc. (WDAY) Finalizes Its Acquisition of Paradox (Insider Monkey)
Oct-10-25 12:25PM	1 S&P 500 Stock for Long-Term Investors and 2 We Ignore (StockStory)
10:08AM	BlackBerry Expands SecuSUITE to Windows for Sovereign-Grade Security (Zacks)
08:02AM	5 Growth Stocks to Strengthen Your Portfolio in Q4 After a Fabulous Q3 (Zacks)
Oct-09-25 09:00AM	The Zacks Rank Explained: How to Find Strong Buy Computer and Technology Stocks (Zacks)
08:59AM	5 Momentum Stocks to Buy for October After a Solid September (Zacks)
07:15AM	3 Artificial Intelligence (AI) Stocks That Are Cheaper Than They Look (Motley Fool)
Oct-07-25 05:50PM	Workday (WDAY) Declines More Than Market: Some Information for Investors (Zacks)
01:15PM	Workday, BILL, Workiva, Zscaler, and Snowflake Stocks Trade Down, What You Need To Know (StockStory)
Oct-06-25 10:07AM	Here's Why ClearBridge Large Cap Growth Strategy Exited Its Position in Workday (WDAY) (Insider Monkey)
09:30AM	Wall Street Analysts See Workday (WDAY) as a Buy: Should You Invest? (Zacks)
Oct-04-25 04:55PM	Workday Completes Paradox Acquisition, Unveils End-to-End AI Hiring Suite (Insider Monkey)
08:00AM	Think AI is a bubble? Here's what you can do about it. (MarketWatch)
Oct-03-25 06:30AM	These AI 'loser' stocks were left for dead. Now it might be their turn to rally. (MarketWatch)
05:33AM	The Zacks Analyst Blog Highlights Mitsubishi UFJ Financial Group, Workday and Ciena (Zacks)
Oct-02-25 09:05AM	Nokia Powers Data Center Connectivity in Singapore: Stock to Gain? (Zacks)
Oct-01-25 05:50PM	Workday (WDAY) Stock Declines While Market Improves: Some Information for Investors (Zacks)
12:45PM	Here is Why Growth Investors Should Buy Workday (WDAY) Now (Zacks)
09:25AM	Qorvo Expands Satcom Portfolio: Will This Boost Prospects? (Zacks)
09:15AM	Workday Completes Acquisition of Paradox (PR Newswire)
07:46AM	October's Top 5 Stocks Poised for Big Breakouts (MarketBeat)
Sep-30-25 09:40AM	MSI Boost Campus Safety at University of Palermo: Stock to Gain? (Zacks)
Sep-26-25 11:30AM	Snowflake (SNOW) Down 8.1% Since Last Earnings Report: Can It Rebound? (Zacks)
11:01AM	Top Stocks From the Staffing Services Industry to Buy Now (Zacks)
Sep-25-25 01:55PM	Jabil Q4 Earnings Surpass Estimates on Strong Revenue Growth (Zacks)
01:51PM	Californias New AI Hiring Rules And Workday Lawsuit Raise Stakes For Employers (AfroTech)
Sep-24-25 04:16PM	Analysts Lift Workday (WDAY) Price Target But Say Growth Is Already Priced In (Insider Monkey)
01:57AM	Workday Unveils Data Cloud with Zero-Copy Integration to Databricks, Salesforce, Snowflake for Real-Time Insights (Insider Monkey)
Sep-22-25 05:43PM	BofA Reaffirms Buy on Workday (WDAY), Maintains $265 Price Target After Analyst Day (Insider Monkey)
05:10PM	Piper Sandler Turns Less Bearish on Workday (WDAY) Following Workday Rising (Insider Monkey)
02:01PM	Is Workday Stock Underperforming the S&P 500? (Barchart)
09:00AM	This Top Computer and Technology Stock is a #1 (Strong Buy): Why It Should Be on Your Radar (Zacks)
08:30AM	These 3 Stocks Boosting Buybacks Have Rallying Potential (MarketBeat)
Sep-20-25 06:18AM	Buy the Dip in These 2 Underperforming Cloud Software Stocks, Say Analysts (TipRanks)
12:44AM	Jim Cramer Calls Workday an Enterprise Software Powerhouse (Insider Monkey)
Sep-19-25 10:15PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
12:50PM	Why Is Workday Stock Surging This Week? (Motley Fool)
11:30AM	Elliott Management Is Betting Big on Workday Stock. Should You? (Barchart)
09:30AM	Should You Invest in Workday (WDAY) Based on Bullish Wall Street Views? (Zacks)
08:43AM	Workday Rising… To Fresh Record High Stock Prices (MarketBeat)
08:25AM	Workday CFO on why $1.1 billion Sana deal aligns with M&A strategy (Fortune)
Sep-18-25 09:50AM	Here's Why Workday (WDAY) is a Strong Momentum Stock (Zacks)
07:00AM	Workdays Plan to Win the AI Agent Race (The Wall Street Journal)
05:21AM	How Workday CEO Carl Eschenbach is pushing employees to get over their fear of AI (Fortune)
02:07AM	Workday Pops as Elliott Discloses $2 Billion Investment (GuruFocus.com)
Sep-17-25 09:15PM	Market movers: Lyft stock accelerates, Workday active, Nvidia slips (TheStreet) +7.25%
08:20PM	Workday CEO Carl Eschenbach: There's a narrative that AI is eating into software, that is false (CNBC TV)
04:55PM	S&P 500 Gains & Losses Today: Uber Stock Skids, Homebuilding Sector Slips; Workday Jumps (Investopedia)
04:53PM	Tech, Media & Telecom Roundup: Market Talk (The Wall Street Journal)
04:46PM	These Stocks Moved the Most Today: Nvidia, StubHub, Workday, Lyft, IonQ, Netflix, and More (Barrons.com)
02:18PM	These Stocks Are Moving the Most Today: Nvidia, StubHub, Workday, Lyft, IonQ, Netflix, and More (Barrons.com)
01:36PM	Workday (WDAY) Shares Skyrocket, What You Need To Know (StockStory)
11:58AM	Workday AI Push Signals Durable Growth And Sharper Margins Ahead (Benzinga)
11:57AM	Top Stock Movers Now: Workday, Lyft, Uber, Nvidia, and More (Investopedia)
11:08AM	Stock Market Today: Dow Jumps 300 Points As Fed Looms; Nvidia Slides, Workday Soars (Live Coverage) (Investor's Business Daily)
10:55AM	Workday Stock Surges on Investor Stake, AI Moves, Upgrades (Schaeffer's Research)
10:50AM	Workday gains, FedEx demand troubles, Ben & Jerry's founder quits (Yahoo Finance Video)
10:45AM	Elliott Management Builds Workday Stake. Margins In Focus At Analyst Day. (Investor's Business Daily)
10:05AM	Workday has just drawn an activist investor. Is it the catalyst the workplace-software stock needs? (MarketWatch)
09:46AM	Workday Stock Jumps as Activist Investor Elliott Takes $2B Stake, Praises Management Plan (Investopedia)
09:46AM	Workday Stock Surges. These 3 Things Are Driving It Higher. (Barrons.com)
09:45AM	Stock Market Today: Dow Climbs Ahead Of Fed Vote; Nvidia Slides On China Ban (Live Coverage) (Investor's Business Daily)
09:44AM	Stocks to Watch Wednesday: StubHub, NIO, Nvidia, General Mills (The Wall Street Journal)
09:39AM	Workday shares jump 8% premarket as activist investor Elliott reveals $2bn stake (Investing.com)

Workday, Inc. engages in the provision of development of enterprise cloud applications for finance and human resources. It delivers financial management, human capital management and analytics applications designed for companies, educational institutions, and government agencies. The company was founded by David A. Duffield and Aneel Bhusri in 2005 and is headquartered in Pleasanton, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Garfield Mark S.	Chief Accounting Officer	Oct 09 '25	Sale	238.96	1,915	457,601	37,351	Oct 14 04:34 PM
MCNAMARA MICHAEL M	Director	Oct 10 '25	Sale	235.16	5,393	1,268,201	24,078	Oct 14 04:32 PM
DUFFIELD DAVID A	10% Owner	Oct 08 '25	Sale	236.34	75,053	17,738,401	102,997	Oct 10 04:31 PM
Michael McNamara	Director	Oct 10 '25	Proposed Sale	235.16	5,393	1,268,201		Oct 10 04:20 PM
MARK GARFIELD	Officer	Oct 09 '25	Proposed Sale	238.25	1,915	456,249		Oct 09 04:18 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 08 '25	Proposed Sale	233.17	75,053	17,500,108		Oct 08 04:20 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Oct 07 '25	Sale	235.87	2,320	547,220	90,077	Oct 07 07:41 PM
Rowe Zane	Chief Financial Officer	Oct 07 '25	Sale	232.62	6,000	1,395,717	168,468	Oct 07 06:48 PM
RICHARD SAUER	Officer	Oct 07 '25	Proposed Sale	238.36	2,320	552,995		Oct 07 04:41 PM
Eschenbach Carl M.	CEO	Oct 01 '25	Sale	237.52	6,250	1,484,504	20,222	Oct 03 06:43 PM
DUFFIELD DAVID A	10% Owner	Oct 01 '25	Sale	235.09	72,696	17,090,277	102,997	Oct 03 04:23 PM
ESCHENBACH FAMILY TRUST	Director	Oct 01 '25	Proposed Sale	240.73	6,250	1,504,562		Oct 01 04:28 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Oct 01 '25	Proposed Sale	240.73	72,696	17,500,108		Oct 01 04:28 PM
DUFFIELD DAVID A	10% Owner	Sep 23 '25	Sale	241.57	72,118	17,421,401	102,997	Sep 25 04:15 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 23 '25	Proposed Sale	242.66	72,118	17,500,154		Sep 23 04:21 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Sep 17 '25	Sale	235.41	1,160	273,076	95,756	Sep 19 04:32 PM
DUFFIELD DAVID A	10% Owner	Sep 16 '25	Sale	220.12	78,564	17,293,603	102,997	Sep 17 04:28 PM
DUFFIELD DAVID A	10% Owner	Sep 15 '25	Sale	222.23	15,000	3,333,516	15,000	Sep 17 04:28 PM
RICHARD SAUER	Officer	Sep 17 '25	Proposed Sale	219.01	1,160	254,052		Sep 17 04:24 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 16 '25	Proposed Sale	222.75	78,564	17,500,131		Sep 16 04:26 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Sep 11 '25	Sale	226.63	1,160	262,891	96,916	Sep 15 04:34 PM
The Dave & Cheryl Duffield Fou	10% Owner	Sep 15 '25	Proposed Sale	223.39	15,000	3,350,850		Sep 15 04:33 PM
RICHARD SAUER	Officer	Sep 11 '25	Proposed Sale	226.48	1,160	262,717		Sep 11 04:23 PM
DUFFIELD DAVID A	10% Owner	Sep 02 '25	Sale	228.16	75,817	17,298,267	102,997	Sep 04 04:15 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Sep 02 '25	Proposed Sale	230.82	75,817	17,500,080		Sep 02 04:40 PM
Garfield Mark S.	Chief Accounting Officer	Jul 10 '25	Sale	234.86	451	105,922	42,977	Jul 14 04:21 PM
DUFFIELD DAVID A	10% Owner	Jul 08 '25	Sale	239.61	72,551	17,384,110	102,997	Jul 10 04:34 PM
MARK GARFIELD	Officer	Jul 10 '25	Proposed Sale	240.17	451	108,317		Jul 10 04:30 PM
Rowe Zane	Chief Financial Officer	Jul 08 '25	Sale	239.59	6,000	1,437,565	178,418	Jul 08 06:23 PM
ZANE ROWE	Officer	Jul 08 '25	Proposed Sale	241.21	12,000	2,894,520		Jul 08 04:23 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jul 08 '25	Proposed Sale	241.21	72,551	17,500,027		Jul 08 04:21 PM
Eschenbach Carl M.	CEO	Jul 01 '25	Sale	239.43	6,250	1,496,435	1,472	Jul 03 04:52 PM
DUFFIELD DAVID A	10% Owner	Jul 01 '25	Sale	238.96	72,917	17,424,176	102,997	Jul 03 04:39 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jul 01 '25	Proposed Sale	240.00	72,917	17,500,080		Jul 01 04:23 PM
DUFFIELD DAVID A	10% Owner	Jun 24 '25	Sale	238.66	73,971	17,654,071	102,997	Jun 26 04:35 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 24 '25	Proposed Sale	236.58	73,971	17,500,059		Jun 24 04:25 PM
DUFFIELD DAVID A	10% Owner	Jun 17 '25	Sale	244.31	71,240	17,404,482	102,997	Jun 18 04:36 PM
DUFFIELD DAVID A	10% Owner	Jun 16 '25	Sale	245.33	15,000	3,679,932	30,000	Jun 18 04:36 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 17 '25	Proposed Sale	245.65	71,240	17,500,106		Jun 17 04:21 PM
The Dave & Cheryl Duffield Fou	10% Owner	Jun 16 '25	Proposed Sale	244.54	15,000	3,668,100		Jun 16 04:32 PM
STILL GEORGE J JR	Director	Jun 05 '25	Sale	248.41	7,500	1,863,101	67,500	Jun 09 04:46 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Jun 05 '25	Proposed Sale	249.48	7,500	1,871,100		Jun 05 05:04 PM
DUFFIELD DAVID A	10% Owner	Jun 02 '25	Sale	246.84	70,648	17,438,932	102,997	Jun 03 04:29 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jun 02 '25	Proposed Sale	247.71	70,648	17,500,216		Jun 02 04:28 PM
Eschenbach Carl M.	CEO	May 27 '25	Sale	241.23	3,125	753,844	7,722	May 29 06:38 PM
ESCHENBACH FAMILY TRUST	Director	May 27 '25	Proposed Sale	238.01	9,375	2,231,344		May 27 04:34 PM
SAYAN CHAKRABORTY	Officer	May 27 '25	Proposed Sale	238.01	12,860	3,060,809		May 27 04:30 PM
Garfield Mark S.	Chief Accounting Officer	Apr 10 '25	Sale	226.55	497	112,595	34,385	Apr 14 06:38 PM
DUFFIELD DAVID A	10% Owner	Apr 08 '25	Sale	214.68	81,275	17,448,053	102,997	Apr 10 04:37 PM
MARK GARFIELD	Officer	Apr 10 '25	Proposed Sale	231.42	497	115,016		Apr 10 04:17 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Apr 08 '25	Proposed Sale	215.32	81,275	17,500,133		Apr 08 04:16 PM
Eschenbach Carl M.	CEO	Apr 02 '25	Sale	234.61	3,125	733,161	10,847	Apr 04 06:14 PM
DUFFIELD DAVID A	10% Owner	Apr 01 '25	Sale	232.94	74,937	17,455,544	102,997	Apr 03 04:08 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Apr 01 '25	Proposed Sale	233.53	74,937	17,500,038		Apr 01 04:26 PM
DUFFIELD DAVID A	10% Owner	Mar 24 '25	Sale	250.26	70,144	17,554,502	102,997	Mar 26 04:58 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 24 '25	Proposed Sale	249.49	70,144	17,500,227		Mar 24 04:22 PM
DUFFIELD DAVID A	10% Owner	Mar 17 '25	Sale	248.58	71,672	17,816,346	102,997	Mar 18 07:00 PM
DUFFIELD DAVID A	10% Owner	Mar 14 '25	Sale	243.17	15,000	3,647,531	45,000	Mar 18 07:00 PM
STILL GEORGE J JR	Director	Mar 13 '25	Sale	241.33	7,500	1,809,991	75,000	Mar 17 07:16 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 17 '25	Proposed Sale	244.17	71,672	17,500,152		Mar 17 04:32 PM
The Dave & Cheryl Duffield Fou	10% Owner	Mar 14 '25	Proposed Sale	237.22	15,000	3,558,300		Mar 14 04:25 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Mar 13 '25	Proposed Sale	241.67	7,500	1,812,525		Mar 13 04:25 PM
DUFFIELD DAVID A	10% Owner	Mar 03 '25	Sale	259.52	66,455	17,246,098	102,997	Mar 05 05:42 PM
Chakraborty Sayan	President, Prod. and Tech.	Feb 27 '25	Sale	265.50	6,056	1,607,858	111,324	Mar 03 07:32 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Mar 03 '25	Proposed Sale	263.34	66,455	17,500,260		Mar 03 04:23 PM
SAYAN CHAKRABORTY	Officer	Feb 27 '25	Proposed Sale	271.09	6,056	1,641,721		Feb 27 04:26 PM
Garfield Mark S.	Chief Accounting Officer	Jan 13 '25	Sale	248.24	472	117,169	35,408	Jan 15 04:33 PM
DUFFIELD DAVID A	10% Owner	Jan 13 '25	Sale	246.42	56,000	13,799,530	60,000	Jan 15 04:32 PM
MARK GARFIELD	Officer	Jan 13 '25	Proposed Sale	249.71	472	117,863		Jan 13 04:25 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Jan 13 '25	Proposed Sale	249.71	56,000	13,983,760		Jan 13 04:24 PM
DUFFIELD DAVID A	10% Owner	Jan 08 '25	Sale	254.53	70,090	17,839,895	102,997	Jan 10 04:17 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 08 '25	Proposed Sale	249.68	70,090	17,500,071		Jan 08 04:21 PM
Eschenbach Carl M.	CEO	Jan 06 '25	Sale	253.86	6,250	1,586,654	13,972	Jan 07 09:19 PM
Sauer Richard Harry	Chief Legal Officer & Secty	Jan 07 '25	Sale	251.90	3,677	926,232	79,576	Jan 07 09:16 PM
DUFFIELD DAVID A	10% Owner	Jan 06 '25	Sale	253.87	56,000	14,216,609	116,000	Jan 07 07:30 PM
RICHARD SAUER	Officer	Jan 07 '25	Proposed Sale	254.14	3,677	934,473		Jan 07 04:17 PM
DUFFIELD DAVID A	10% Owner	Jan 02 '25	Sale	252.83	67,822	17,147,554	102,997	Jan 06 04:29 PM
ESCHENBACH FAMILY TRUST	Director	Jan 06 '25	Proposed Sale	252.84	12,500	3,160,500		Jan 06 04:27 PM
Frederick Wayne A.I.	Director	Jan 02 '25	Sale	253.09	1,829	462,904	6,845	Jan 06 04:25 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Jan 06 '25	Proposed Sale	252.84	56,000	14,159,040		Jan 06 04:23 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Jan 02 '25	Proposed Sale	258.03	67,822	17,500,111		Jan 02 04:26 PM
WAYNE FREDERICK	Director	Jan 02 '25	Proposed Sale	258.03	1,829	471,937		Jan 02 04:25 PM
DUFFIELD DAVID A	10% Owner	Dec 30 '24	Sale	261.75	56,000	14,657,896	172,000	Dec 31 04:40 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Dec 30 '24	Proposed Sale	266.24	56,000	14,909,440		Dec 30 04:10 PM
DUFFIELD DAVID A	10% Owner	Dec 23 '24	Sale	265.70	56,000	14,878,925	228,000	Dec 26 04:44 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Dec 23 '24	Proposed Sale	273.04	56,000	15,290,240		Dec 23 04:18 PM
DUFFIELD DAVID A	10% Owner	Dec 18 '24	Sale	275.31	57,000	15,692,813	284,000	Dec 20 04:19 PM
DAVE & CHERYL DUFFIELD FOUNDAT	10% Owner	Dec 18 '24	Proposed Sale	278.01	57,000	15,846,570		Dec 18 04:26 PM
STILL GEORGE J JR	Director	Dec 16 '24	Sale	276.54	7,500	2,074,041	82,500	Dec 18 04:22 PM
DUFFIELD DAVID A	10% Owner	Dec 16 '24	Sale	276.56	63,946	17,684,813	102,997	Dec 18 04:18 PM
STILL FAMILY TRUST U/A DTD 03/	Director	Dec 16 '24	Proposed Sale	273.67	7,500	2,052,525		Dec 16 04:37 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 16 '24	Proposed Sale	273.67	63,946	17,500,102		Dec 16 04:37 PM
James Bozzini	Director	Dec 09 '24	Proposed Sale	279.91	18,696	5,233,197		Dec 09 05:25 PM
DUFFIELD DAVID A	10% Owner	Dec 02 '24	Sale	251.20	70,003	17,585,013	102,997	Dec 04 06:25 PM
Chakraborty Sayan	President, Prod. and Tech.	Nov 29 '24	Sale	250.78	5,498	1,378,767	121,100	Dec 03 05:39 PM
THE DAVID A DUFFIELD TRUST U/T	10% Owner	Dec 02 '24	Proposed Sale	249.99	70,003	17,500,050		Dec 02 04:44 PM
SAYAN CHAKRABORTY	Officer	Nov 29 '24	Proposed Sale	253.40	5,498	1,393,193		Nov 29 01:43 PM

TEM

Tempus AI Inc

PODD

Insulet Corporation

WDAY

Workday Inc

Upgrade your FINVIZ experience